Primary prevention of type 2 diabetes: there are no simple solutions!
- PMID: 19638532
- PMCID: PMC2712793
- DOI: 10.2337/db09-0840
Primary prevention of type 2 diabetes: there are no simple solutions!
Comment on
-
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.Diabetes. 2009 Aug;58(8):1921-8. doi: 10.2337/db09-0087. Epub 2009 Jun 2. Diabetes. 2009. PMID: 19491213 Free PMC article. Clinical Trial.
Similar articles
-
Reducing coronary artery disease by decreasing homocysteine levels.Crit Care Nurse. 2003 Feb;23(1):25-30. Crit Care Nurse. 2003. PMID: 12640957 Review. No abstract available.
-
[Management of IGT education program at a hospital and its primary prevention effect on diabetes mellitus].Nihon Rinsho. 2005 Feb;63 Suppl 2:582-7. Nihon Rinsho. 2005. PMID: 15779444 Review. Japanese. No abstract available.
-
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.Diabetes. 2009 Aug;58(8):1921-8. doi: 10.2337/db09-0087. Epub 2009 Jun 2. Diabetes. 2009. PMID: 19491213 Free PMC article. Clinical Trial.
-
The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS).Stroke. 2011 Mar;42(3):838-42. doi: 10.1161/STROKEAHA.110.608356. Epub 2011 Jan 27. Stroke. 2011. PMID: 21273566 Review. No abstract available.
-
[Primary prevention of type 2 diabetes mellitus according to lifestyle intervention--the process and for the future].Nihon Rinsho. 2002 Sep;60 Suppl 9:52-99. Nihon Rinsho. 2002. PMID: 12386979 Review. Japanese. No abstract available.
References
-
- Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Finnish Diabetes Prevention Study Group Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343– 1350 - PubMed
-
- DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368: 1096– 1105 ( erratum in Lancet 2006;368:1770) - PubMed
-
- Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796– 2803 - PubMed
-
- Cho NH, Lim S, Jang HC, Park HK, Metzger BE: Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study. Diabetes Care 2005; 28: 2750– 2755 - PubMed